Maintaining cell identity: PRC2-mediated regulation of transcription and cancer (Q38961785)

8 September 2017

title

Maintaining cell identity: PRC2-mediated regulation of transcription and cancer (English)

1 reference

8 September 2017

4

1 reference

8 September 2017

Itys Comet

1

0 references

Benjamin Leblanc

object named as

Benjamin Leblanc

series ordinal

3

0 references

Eva M Riising

object named as

Eva M Riising

series ordinal

2

0 references

publication date

23 September 2016

1 reference

8 September 2017

language of work or name

English

0 references

published in

Nature Reviews Cancer

1 reference

8 September 2017

volume

16

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

803-810

1 reference

publication type of scholarly work

8 September 2017

review article

1 reference

Chromatin proteins and modifications as drug targets

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Chromatin Repressive Complexes in Stem Cells, Development, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Occupying Chromatin: Polycomb Mechanisms for Getting to Genomic Targets, Stopping Transcriptional Traffic, and Staying Put

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The Polycomb complex PRC2 and its mark in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Polycomb Group proteins: an evolutionary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Analysis of the coding genome of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Context-dependent actions of Polycomb repressors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Targeting Polycomb systems to regulate gene expression: modifications to a complex story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The controversial role of the Polycomb group proteins in transcription and cancer: how much do we not understand Polycomb proteins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A gene complex controlling segmentation in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Suz12 binds to silenced regions of the genome in a cell-type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Polycomb complexes repress developmental regulators in murine embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Control of developmental regulators by Polycomb in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Chromosomal distribution of PcG proteins during Drosophila development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Genome-wide analysis of Polycomb targets in Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Genome-wide profiling of PRC1 and PRC2 Polycomb chromatin binding in Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

H3K36me3 key to Polycomb-mediated gene silencing in lineage specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Silencing chromatin: comparing modes and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A new world of Polycombs: unexpected partnerships and emerging functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A double take on bivalent promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Dense Chromatin Activates Polycomb Repressive Complex 2 to Regulate H3 Lysine 27 Methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Ras-Induced Changes in H3K27me3 Occur after Those in Transcriptional Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Short sequences can efficiently recruit histone H3 lysine 27 trimethylation in the absence of enhancer activity and DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

GC-rich sequence elements recruit PRC2 in mammalian ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Chromatin sampling--an emerging perspective on targeting polycomb repressor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Epigenetics: Core misconcept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 mutations are frequent and represent an early event in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 expands breast stem cells through activation of NOTCH1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Regulation of tumor angiogenesis by EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Polycomb repressive complex 2 is required for MLL-AF9 leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The Polycomb-group gene eed regulates thymocyte differentiation and suppresses the development of carcinogen-induced T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Epigenetic stem cell signature in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A DNA hypermethylation module for the stem/progenitor cell signature of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Revolution in the Polycomb hierarchy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A687V EZH2 is a gain‐of‐function mutation found in lymphoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.83

Ten different Polycomb group genes are required for spatial control of the abdA and AbdB homeotic products

31 March 2020

1 reference

12 December 2020

Altered distributions of Ultrabithorax transcripts in extra sex combs mutant embryos of Drosophila

1 reference

12 December 2020

The molecular basis for metameric pattern in the Drosophila embryo

1 reference

12 December 2020

Genetic analysis of the enhancer of zeste locus and its role in gene regulation in Drosophila melanogaster

1 reference

12 December 2020

Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis

1 reference

12 December 2020

Recruitment of components of Polycomb Group chromatin complexes in Drosophila

1 reference

12 December 2020

The molecular basis for metameric pattern in the Drosophila embryo

1 reference

19 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1242/DEV.101.1.1

Identifiers

DOI

10.1038/NRC.2016.83

1 reference

Dimensions Publication ID

8 September 2017

1027309366

0 references

1 reference